Cargando…
Nanophytomedicines for the Prevention of Metabolic Syndrome: A Pharmacological and Biopharmaceutical Review
Metabolic syndrome includes a series of metabolic abnormalities that leads to diabetes mellitus and cardiovascular diseases. Plant extracts, due to their unique advantages like anti-inflammatory, antioxidant, and insulin sensitizing properties, are interesting therapeutic options to manage MetS; how...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7240035/ https://www.ncbi.nlm.nih.gov/pubmed/32478050 http://dx.doi.org/10.3389/fbioe.2020.00425 |
_version_ | 1783536799892635648 |
---|---|
author | Nouri, Zeinab Hajialyani, Marziyeh Izadi, Zhila Bahramsoltani, Roodabeh Farzaei, Mohammad Hosein Abdollahi, Mohammad |
author_facet | Nouri, Zeinab Hajialyani, Marziyeh Izadi, Zhila Bahramsoltani, Roodabeh Farzaei, Mohammad Hosein Abdollahi, Mohammad |
author_sort | Nouri, Zeinab |
collection | PubMed |
description | Metabolic syndrome includes a series of metabolic abnormalities that leads to diabetes mellitus and cardiovascular diseases. Plant extracts, due to their unique advantages like anti-inflammatory, antioxidant, and insulin sensitizing properties, are interesting therapeutic options to manage MetS; however, the poor solubility and low bioavailability of lipophilic bioactive components in the herbal extracts are two critical challenges. Nano-scale delivery systems are suitable to improve delivery of herbal extracts. This review, for the first time, focuses on nanoformulations of herbal extracts in MetS and related complications. Included studies showed that several forms of nano drug delivery systems such as nanoemulsions, solid lipid nanoparticles, nanobiocomposites, and green-synthesized silver, gold, and zinc oxide nanoparticles have been developed using herbal extracts. It was shown that the method of preparation and related parameters such as temperature and type of polymer are important factors affecting physicochemical stability and therapeutic activity of the final product. Many of these formulations could successfully decrease the lipid profile, inflammation, oxidative damage, and insulin resistance in in vitro and in vivo models of MetS-related complications. Further studies are still needed to confirm the safety and efficacy of these novel herbal formulations for clinical application. |
format | Online Article Text |
id | pubmed-7240035 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-72400352020-05-29 Nanophytomedicines for the Prevention of Metabolic Syndrome: A Pharmacological and Biopharmaceutical Review Nouri, Zeinab Hajialyani, Marziyeh Izadi, Zhila Bahramsoltani, Roodabeh Farzaei, Mohammad Hosein Abdollahi, Mohammad Front Bioeng Biotechnol Bioengineering and Biotechnology Metabolic syndrome includes a series of metabolic abnormalities that leads to diabetes mellitus and cardiovascular diseases. Plant extracts, due to their unique advantages like anti-inflammatory, antioxidant, and insulin sensitizing properties, are interesting therapeutic options to manage MetS; however, the poor solubility and low bioavailability of lipophilic bioactive components in the herbal extracts are two critical challenges. Nano-scale delivery systems are suitable to improve delivery of herbal extracts. This review, for the first time, focuses on nanoformulations of herbal extracts in MetS and related complications. Included studies showed that several forms of nano drug delivery systems such as nanoemulsions, solid lipid nanoparticles, nanobiocomposites, and green-synthesized silver, gold, and zinc oxide nanoparticles have been developed using herbal extracts. It was shown that the method of preparation and related parameters such as temperature and type of polymer are important factors affecting physicochemical stability and therapeutic activity of the final product. Many of these formulations could successfully decrease the lipid profile, inflammation, oxidative damage, and insulin resistance in in vitro and in vivo models of MetS-related complications. Further studies are still needed to confirm the safety and efficacy of these novel herbal formulations for clinical application. Frontiers Media S.A. 2020-05-14 /pmc/articles/PMC7240035/ /pubmed/32478050 http://dx.doi.org/10.3389/fbioe.2020.00425 Text en Copyright © 2020 Nouri, Hajialyani, Izadi, Bahramsoltani, Farzaei and Abdollahi. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Bioengineering and Biotechnology Nouri, Zeinab Hajialyani, Marziyeh Izadi, Zhila Bahramsoltani, Roodabeh Farzaei, Mohammad Hosein Abdollahi, Mohammad Nanophytomedicines for the Prevention of Metabolic Syndrome: A Pharmacological and Biopharmaceutical Review |
title | Nanophytomedicines for the Prevention of Metabolic Syndrome: A Pharmacological and Biopharmaceutical Review |
title_full | Nanophytomedicines for the Prevention of Metabolic Syndrome: A Pharmacological and Biopharmaceutical Review |
title_fullStr | Nanophytomedicines for the Prevention of Metabolic Syndrome: A Pharmacological and Biopharmaceutical Review |
title_full_unstemmed | Nanophytomedicines for the Prevention of Metabolic Syndrome: A Pharmacological and Biopharmaceutical Review |
title_short | Nanophytomedicines for the Prevention of Metabolic Syndrome: A Pharmacological and Biopharmaceutical Review |
title_sort | nanophytomedicines for the prevention of metabolic syndrome: a pharmacological and biopharmaceutical review |
topic | Bioengineering and Biotechnology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7240035/ https://www.ncbi.nlm.nih.gov/pubmed/32478050 http://dx.doi.org/10.3389/fbioe.2020.00425 |
work_keys_str_mv | AT nourizeinab nanophytomedicinesforthepreventionofmetabolicsyndromeapharmacologicalandbiopharmaceuticalreview AT hajialyanimarziyeh nanophytomedicinesforthepreventionofmetabolicsyndromeapharmacologicalandbiopharmaceuticalreview AT izadizhila nanophytomedicinesforthepreventionofmetabolicsyndromeapharmacologicalandbiopharmaceuticalreview AT bahramsoltaniroodabeh nanophytomedicinesforthepreventionofmetabolicsyndromeapharmacologicalandbiopharmaceuticalreview AT farzaeimohammadhosein nanophytomedicinesforthepreventionofmetabolicsyndromeapharmacologicalandbiopharmaceuticalreview AT abdollahimohammad nanophytomedicinesforthepreventionofmetabolicsyndromeapharmacologicalandbiopharmaceuticalreview |